Provider review
Docberry review
A supply package rather than monthly flexibility.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
Semaglutide $796/4 months; tirzepatide $1,745/3 months
Visit DocberryThe public offers price multi-month injection supplies without a weekly dose or a separate microdose plan.
Price as published
Docberry
Semaglutide $796/4 months; tirzepatide $1,745/3 months
- Vs median
- Not comparable — published against a multi-month block with no monthly rung, so a per-month figure would be one we calculated rather than one they published
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Docberry is a package purchase. The longer semaglutide option reduces the advertised monthly equivalent, but it also asks the buyer to commit to much more medication at once. The tirzepatide total covers a different duration, making a comparison based only on the large monthly numbers misleading. Someone seeking a smaller dose needs the prescribed quantity, the pharmacy label and the next refill price before deciding whether the supply will provide useful value. Financing does not remove those questions.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You prefer buying a defined multi-month supply
- You want the full package price before an online evaluation
Look elsewhere if
- You need a small initial financial commitment
- You need the weekly dose printed beside the advertised price
What it actually costs
Price as published
Semaglutide $796/4 months; tirzepatide $1,745/3 months
- Vs median
- Not comparable — published against a multi-month block with no monthly rung, so a per-month figure would be one we calculated rather than one they published
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. The public offers price multi-month injection supplies without a weekly dose or a separate microdose plan.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Confirm any separate fee
- Dietitian
- Not confirmed
- Labs
- Not stated
- Pricing
- Check plan terms
What it does well
- Full supply totals are printed beside the monthly equivalents
- Medication is delivered with administration instructions
- An online evaluation precedes prescribing
Pharmacy, labs and oversight
Docberry does not publicly identify the pharmacy that fills its prescriptions. Laboratory requirements are not publicly stated; confirm them with the clinician. Confirm whether clinician visits cost extra.
Transparency check
2 of 4 published openly
What Docberry publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Docberry sells semaglutide and tirzepatide through an online evaluation and delivery service. The public prices are multi-month supply totals, not independent monthly subscriptions. Semaglutide has both four- and twelve-month options, while the tirzepatide offer covers three months. The site describes self-administered injections and shipment with instructions. Medical services come from independent physicians and practitioners rather than Docberry itself, and payment does not guarantee a prescription. The price cards do not identify the weekly dose, the dispensing pharmacy or a distinct microdose product. Installment financing is advertised, which changes how a package is paid for rather than converting it into month-to-month care. The public treatment information does not establish a mandatory laboratory schedule; confirm testing requirements with the clinician.
The honest cons
The low monthly semaglutide figure requires a twelve-month purchase
- The dose and refill price after the initial package are not printed beside the offer
- A dispensing pharmacy is not named on the treatment page
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Docberry is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Docberry does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Where this sits
#498 of 548
Ordered with the companies that pay us first, and Docberry is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Direct Meds
From $249/mo sublingual · $297/mo injection
FDA warning letter · Direct Meds · September 2025 · addressed to directmeds.com, Inc. dba DirectMeds. Details in our review.
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by CraftedRx · ChemistryRx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Direct Meds review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.